+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hyperimmune Globulin Product Market - Global Forecast 2025-2030- Product Image
Hyperimmune Globulin Product Market - Global Forecast 2025-2030- Product Image
Sale

Hyperimmune Globulin Product Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127436
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hyperimmune globulin market in 2025 stands at a pivotal point, shaped by accelerated biopharmaceutical advances, adaptive patient care models, and global regulatory shifts. Senior decision-makers face both strategic opportunities and operational challenges as the industry rapidly evolves across indications and geographies.

Market Snapshot: Hyperimmune Globulin Therapy

Hyperimmune globulin therapy is now central to managing immunological and hematological disorders and offers an important therapeutic solution for primary immune deficiencies, chronic inflammatory demyelinating polyneuropathy, immune thrombocytopenia purpura, and Kawasaki disease. Market growth is driven by innovation in plasma fractionation, improved antibody specificity, and the adoption of advanced purification and viral inactivation techniques. The sector is further shaped by robust regulatory frameworks and the evolving landscape of reimbursement and patient access.

Scope & Segmentation

  • Product Types: Intramuscular Immune Globulin, Intravenous Immune Globulin, Subcutaneous Immune Globulin (Infusion Pump, Rapid Push)
  • Indications: Chronic Inflammatory Demyelinating Polyneuropathy, Immune Thrombocytopenia Purpura, Kawasaki Disease, Primary Immune Deficiencies
  • Routes of Administration: Intramuscular, Intravenous, Subcutaneous (Infusion Pump, Rapid Push)
  • Distribution Channels: Clinic Pharmacy, Hospital Pharmacy, Online Pharmacy (Direct To Consumer, Prescription Fulfillment), Retail Pharmacy
  • End Users: Home Healthcare Settings (Nurse Assisted, Self Administration), Hospitals (Community, Specialized, Tertiary Care Centers), Specialty Clinics (Immunology, Neurology Clinics)
  • Regional Coverage: Americas (including United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (key countries include United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: CSL Limited, Grifols S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, Kedrion S.p.A., Laboratoire français du fractionnement et des biotechnologies, Biotest AG, Shanghai RAAS Blood Products Co., Ltd., Bio Products Laboratory Ltd, ADMA Biologics, Inc.

Key Takeaways for Senior Decision-Makers

  • Emerging patient-centric treatment options, such as home-based subcutaneous administration and digital therapy support, are transforming care delivery, particularly for chronic disease management.
  • Recent advancements in plasma purification, antibody characterization, and scalable fractionation are improving product safety and treatment outcomes.
  • Regulatory harmonization in major regions is creating more predictable approval pathways and accelerating the introduction of novel hyperimmune globulin therapies.
  • Distribution strategies are expanding through online pharmacy channels, supporting both direct-to-consumer and prescription-based models.
  • Leading pharmaceutical companies are leveraging portfolio optimization, advanced manufacturing, and strategic partnerships to remain competitive and introduce differentiated product offerings.

Tariff Impact in the United States

Targeted tariff adjustments on plasma-derived biologics in the U.S. are reshaping cost structures and supply chains. The added import duties on key intermediates and finished products increase acquisition expenses, particularly for firms relying on international plasma pools. These changes are driving increased domestic production capacity, influencing sourcing partnerships, and intensifying competition. Many companies are re-evaluating pricing strategies, pursuing alternative sourcing, and negotiating value-based procurement models to maintain affordability and access.

Methodology & Data Sources

This report draws on structured interviews with executive leaders, industry experts, and clinical specialists, supplemented by reviews of peer-reviewed literature, policy papers, and market analyses. Data triangulation, thematic analysis, and expert validation ensure robust, actionable conclusions for each market segment and region.

Why This Hyperimmune Globulin Report Matters

  • Provides a comprehensive, segmented overview of the global hyperimmune globulin sector with actionable recommendations for biopharma executives and market strategists.
  • Details the interplay of clinical demand, technology innovation, regulatory policy, and supply chain trends crucial for risk mitigation and investment decisions.
  • Supports operational optimization with a practical roadmap based on real-world perspectives, competitive insights, and regional market dynamics.

Conclusion

The hyperimmune globulin market is in transition, driven by patient-centric care, innovative manufacturing, and evolving policy. Companies equipped with strategic insights and adaptive capabilities are best positioned for sustained success and growth in this critical therapeutic area.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing demand for pathogen-specific hyperimmune globulins targeting emerging infectious diseases such as COVID-19 and Ebola
5.2. Rising investments in monoclonal antibody technologies to enhance hyperimmune globulin specificity and efficacy
5.3. Expansion of plasma donation networks in developing regions to secure consistent supply of hyperimmune globulin products
5.4. Regulatory approvals of next-generation hyperimmune globulin formulations for prophylactic and therapeutic indications
5.5. Integration of advanced purification techniques to reduce intravenous immunoglobulin-associated adverse reactions
5.6. Strategic partnerships between biopharmaceutical companies and plasma centers to accelerate hyperimmune globulin development
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hyperimmune Globulin Product Market, by Product Type
8.1. Introduction
8.2. Intramuscular Immune Globulin
8.3. Intravenous Immune Globulin
8.4. Subcutaneous Immune Globulin
8.4.1. Infusion Pump
8.4.2. Rapid Push
9. Hyperimmune Globulin Product Market, by Indication
9.1. Introduction
9.2. Chronic Inflammatory Demyelinating Polyneuropathy
9.3. Immune Thrombocytopenia Purpura
9.4. Kawasaki Disease
9.5. Primary Immune Deficiencies
10. Hyperimmune Globulin Product Market, by Route of Administration
10.1. Introduction
10.2. Intramuscular
10.3. Intravenous
10.4. Subcutaneous
10.4.1. Infusion Pump
10.4.2. Rapid Push
11. Hyperimmune Globulin Product Market, by Distribution Channel
11.1. Introduction
11.2. Clinic Pharmacy
11.3. Hospital Pharmacy
11.4. Online Pharmacy
11.4.1. Direct to Consumer
11.4.2. Prescription Fulfillment
11.5. Retail Pharmacy
12. Hyperimmune Globulin Product Market, by End User
12.1. Introduction
12.2. Home Healthcare Settings
12.2.1. Nurse Assisted
12.2.2. Self Administration
12.3. Hospitals
12.3.1. Community Hospitals
12.3.2. Specialized Centers
12.3.3. Tertiary Care Centers
12.4. Specialty Clinics
12.4.1. Immunology Clinics
12.4.2. Neurology Clinics
13. Americas Hyperimmune Globulin Product Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hyperimmune Globulin Product Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hyperimmune Globulin Product Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. CSL Limited
16.3.2. Grifols, S.A.
16.3.3. Takeda Pharmaceutical Company Limited
16.3.4. Octapharma AG
16.3.5. Kedrion S.p.A.
16.3.6. Laboratoire français du fractionnement et des biotechnologies
16.3.7. Biotest AG
16.3.8. Shanghai RAAS Blood Products Co., Ltd.
16.3.9. Bio Products Laboratory Ltd
16.3.10. ADMA Biologics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HYPERIMMUNE GLOBULIN PRODUCT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HYPERIMMUNE GLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HYPERIMMUNE GLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HYPERIMMUNE GLOBULIN PRODUCT MARKET: RESEARCHAI
FIGURE 26. HYPERIMMUNE GLOBULIN PRODUCT MARKET: RESEARCHSTATISTICS
FIGURE 27. HYPERIMMUNE GLOBULIN PRODUCT MARKET: RESEARCHCONTACTS
FIGURE 28. HYPERIMMUNE GLOBULIN PRODUCT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HYPERIMMUNE GLOBULIN PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INTRAMUSCULAR IMMUNE GLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INTRAMUSCULAR IMMUNE GLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INTRAVENOUS IMMUNE GLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INTRAVENOUS IMMUNE GLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INFUSION PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY RAPID PUSH, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY RAPID PUSH, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY IMMUNE THROMBOCYTOPENIA PURPURA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY IMMUNE THROMBOCYTOPENIA PURPURA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRIMARY IMMUNE DEFICIENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRIMARY IMMUNE DEFICIENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INFUSION PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY RAPID PUSH, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY RAPID PUSH, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY CLINIC PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY CLINIC PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRESCRIPTION FULFILLMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRESCRIPTION FULFILLMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY NURSE ASSISTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY NURSE ASSISTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY IMMUNOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY IMMUNOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 142. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 143. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 148. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 149. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 152. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 153. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 156. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 157. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 160. CANADA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 164. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 165. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 276. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 277. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. FRANCE HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. FRANCE HYPERIMMUNE GLOBULIN PRODUCT MARKET SIZE, BY SUBCUTANEOUS IMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 298. FRANC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hyperimmune Globulin Product market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Kedrion S.p.A.
  • Laboratoire français du fractionnement et des biotechnologies
  • Biotest AG
  • Shanghai RAAS Blood Products Co., Ltd.
  • Bio Products Laboratory Ltd
  • ADMA Biologics, Inc.

Related Topics

Related Reports

Hyperimmune Globulin Injection Market - Global Forecast to 2030 - Product Image

Hyperimmune Globulin Injection Market - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Hyperimmune Globulins Market Report 2025 - Product Image

Hyperimmune Globulins Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Gamma Globulin Therpeautic Agent Market - Global Forecast 2025-2030 - Product Image

Gamma Globulin Therpeautic Agent Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Hizentra Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Hizentra Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Immune Globulin Subcutaneous Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Immune Globulin Subcutaneous Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 72 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.